Research Topics
| M D AlthuisSummaryAffiliation: National Institutes of Health Country: USA Publications
|
Detail Information
Publications
Glucose and insulin responses to dietary chromium supplements: a meta-analysisMichelle D Althuis
Statistics Collaborative, Inc, Washington, DC, USA
Am J Clin Nutr 76:148-55. 2002....- Hormonal content and potency of oral contraceptives and breast cancer risk among young womenM D Althuis
Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 7084, EPS MSC 7234, Rockville, MD 20852 USA
Br J Cancer 88:50-7. 2003..Our findings suggest that newer low-potency/low oestrogen dose oral contraceptives may impart a lower risk of breast cancer than that associated with earlier high-potency/high-dose preparations... - Breast cancers among very young premenopausal women (United States)Michelle D Althuis
National Cancer Institute, Rockville, MD, USA
Cancer Causes Control 14:151-60. 2003..To assess risk factors for breast cancer among very young compared to older premenopausal women... - Uterine cancer after use of clomiphene citrate to induce ovulationMichelle D Althuis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7234, USA
Am J Epidemiol 161:607-15. 2005..52, 95% CI: 1.5, 108.0). Clomiphene may increase uterine cancer risk, with higher doses leading to higher risk. Long-term follow-up of infertility cohorts is necessary to clarify the association between clomiphene use and uterine cancer... - Ovarian cancer risk associated with varying causes of infertilityLouise A Brinton
Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Bethesda, MD 20852, USA
Fertil Steril 82:405-14. 2004..To evaluate the risk of ovarian cancer as related to underlying causes of infertility... - Breast cancer risk associated with ovulation-stimulating drugsLouise A Brinton
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Hum Reprod 19:2005-13. 2004..Despite the recognized role of hormones in the aetiology of breast cancer, there has been little evaluation of hormonal preparations used to treat infertility... - Ovarian cancer risk after the use of ovulation-stimulating drugsLouise A Brinton
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 7068, Bethesda, MD 20852 7234, USA
Obstet Gynecol 103:1194-203. 2004..To assess the long-term effects of ovulation-stimulating drugs on the risk of ovarian cancer... - Is male breast cancer similar or different than female breast cancer?William F Anderson
NCI Division of Cancer Prevention, Bethesda, MD 20892 7317, USA
Breast Cancer Res Treat 83:77-86. 2004..To determine if male breast carcinogenesis was similar to its more common female counterpart, we compared incidence patterns among men and women with breast cancer... - Causes of infertility as predictors of subsequent cancer riskLouise A Brinton
National Cancer Institute, Rockville, Maryland 20852-7234, USA
Epidemiology 16:500-7. 2005..85; 0.9-9.5) and uterine (3.15; 1.0-9.5) cancers. CONCLUSIONS: The effects of infertility may extend beyond gynecologic cancers. Thyroid cancers and melanomas deserve specific attention, particularly with respect to endometriosis... - Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugsMichelle D Althuis
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Am J Obstet Gynecol 193:668-74. 2005..CONCLUSION: Fertility drugs do not appear to have strong effects on these cancers. Nonetheless, follow-up should be pursued to assess long-term risks and to monitor effects among women who remain nulliparous... - Global trends in breast cancer incidence and mortality 1973-1997Michelle D Althuis
Hormone and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS MSC 7234, Rockville, MD 20852, USA
Int J Epidemiol 34:405-12. 2005..Future studies assessing the combined contributions of both environmental and hereditary factors may provide explanations for worldwide differences in incidence and mortality rates... - Etiology of hormone receptor-defined breast cancer: a systematic review of the literatureMichelle D Althuis
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Room 7084, 6120 Executive Boulevard, Rockville, MD 20852, USA
Cancer Epidemiol Biomarkers Prev 13:1558-68. 2004..Large population-based studies of determinants of hormone receptor-defined breast cancers defined using state-of-the-art quantitative immunostaining methods are needed to clarify the role of ER/PR expression in breast cancer etiology... - Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in ChinaGabriella Andreotti
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
Int J Cancer 122:2322-9. 2008..Our findings support a role for serum lipids in gallstone development and biliary carcinogenesis... - Oral contraceptives and the risk of breast cancerMichelle D Althuis
N Engl J Med 347:1448-9; author reply 1448-9. 2002